article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

This is going to lead to a lot of health problems and associated costs. Increased provider consolidation has decreased individual market competition, in which lower prices, improved productivity, and innovation can occur. 1ne: A new analysis predicts that by 2030, 48.9% of adults in the United States will be obese, and 24.2%

article thumbnail

Pharma R&D productivity dips, but efficiency gains give hope

Clarivate

Figure 1 illustrates the trend in the number of NMEs first launched onto the world market between 2013 and 2022. In fact, the number of NMEs has grown by 65% between 2013 and 2022. Looking at NMEs launched globally in 2022 paints a gloomy picture at first sight, with a 28% drop from 2021 to 2022.

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Kyowa Kirin drops Nourianz follow-up KW-6356 for Parkinson’s

pharmaphorum

.” KW-6356 is a follow-up to Kyowa Kirin’s first-generation adenosine A2 antagonist Nourianz/Nouriast (istradefylline), which finally claimed FDA approval in 2019 as an add-on to levodopa in Parkinson’s after more than two decades of R&D and has been available in Japan since 2013. billion yen (around $68 million).

article thumbnail

Developments In B2B Healthcare Marketing

Scott’s Directories

The healthcare industry is pretty competitive, recording massive growth yearly. With modern digital marketing tools, healthcare marketers can focus on finding quality leads without expensive expos. Here are some developments in B2B healthcare marketing that can help stay competitive in the healthcare industry.

article thumbnail

Amarin Makes Moves towards Global Expansion of Vazkepa

Pharmaceutical Technology

The World Health Organization (WHO) reports that cardiovascular disease is the major leading cause of death, with 17.9 In 2021, the WHO and the United Nations announced a plan to reduce premature mortality related to noncommunicable diseases, including cardiovascular disease, by 25% leading up to 2025. The company’s market cap is $455.6

article thumbnail

5 Best SalesRabbit Alternatives for Field Sales Teams

Spotio

Map-based data visualization, location-based insights, and optimization and automation tools are essential for field sales teams to succeed in a rapidly-growing competitive landscape. They check off quite a few main boxes while delivering valuable solutions for team management, customer/lead management, lead tracking, and more.

Sales 52
article thumbnail

Cell and gene therapy: manufacturing and talent trends 2023

European Pharmaceutical Review

Overall, as summarised in CGT’s GMP Manufacturing report, among a challenging global economic landscape, intense global competition and technology innovation persisting at the forefront of change in the cell and gene therapy industry, immediate action is needed to support the future of the sector.